LOADING
Comparing AbbVie Inc (ABBV) and Salesforce Inc (CRM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | CRM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $454.4B | $203.9B |
| P/E Ratio | 72.4 | 22.7 |
| Forward P/E | 15.9 | 14.9 |
| PEG Ratio | 0.53 | 0.83 |
| EPS | $3.55 | $10.92 |
| Revenue Growth (YoY) | 10.2% | 10.8% |
| Profit Margin | 9.8% | 22.0% |
| Return on Equity | 62.3% | 19.4% |
| Dividend Yield | 2.68% | 0.70% |
| Beta | 0.28 | 1.20 |
| 52-Week High | $267.47 | $268.27 |
| 52-Week Low | $189.40 | $146.32 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Salesforce Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Salesforce Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.